Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain
Jarred Younger, Luke Parkitny, David McLain
Clinical Rheumatology (2014) Vol. 33, Iss. 4, pp. 451-459
Open Access | Times Cited: 216

Showing 1-25 of 216 citing articles:

Neurogenic neuroinflammation in fibromyalgia and complex regional pain syndrome
G. Littlejohn
Nature Reviews Rheumatology (2015) Vol. 11, Iss. 11, pp. 639-648
Closed Access | Times Cited: 151
Complex regional pain syndrome: a recent update
En Lin Goh, Swathikan Chidambaram, Daqing Ma
Burns & Trauma (2017) Vol. 5
Open Access | Times Cited: 149
Neuropathic Corneal Pain
G. Dieckmann, Sunali Goyal, Pedram Hamrah
Ophthalmology (2017) Vol. 124, Iss. 11, pp. S34-S47
Open Access | Times Cited: 139
Low-Dose Naltrexone (LDN)—Review of Therapeutic Utilization
Karlo Toljan, Bruce Vrooman
Medical Sciences (2018) Vol. 6, Iss. 4, pp. 82-82
Open Access | Times Cited: 120
The Safety and Efficacy of Low‐Dose Naltrexone in the Management of Chronic Pain and Inflammation in Multiple Sclerosis, Fibromyalgia, Crohn's Disease, and Other Chronic Pain Disorders
Denise K. Patten, Bob G. Schultz, Daniel J. Berlau
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2018) Vol. 38, Iss. 3, pp. 382-389
Open Access | Times Cited: 111
Chronic Pain Management in the Elderly
Josianna Schwan, Joseph A. Sclafani, Vivianne L. Tawfik
Anesthesiology Clinics (2019) Vol. 37, Iss. 3, pp. 547-560
Open Access | Times Cited: 104
Reduced Pro-Inflammatory Cytokines after Eight Weeks of Low-Dose Naltrexone for Fibromyalgia
Luke Parkitny, Jarred Younger
Biomedicines (2017) Vol. 5, Iss. 2, pp. 16-16
Open Access | Times Cited: 88
Safety and efficacy of low dose naltrexone in a long covid cohort; an interventional pre-post study
Brendan O’Kelly, Louise Vidal, Tina McHugh, et al.
Brain Behavior & Immunity - Health (2022) Vol. 24, pp. 100485-100485
Open Access | Times Cited: 56
The Relationship Between Chronic Pain and Cognitive Impairment in the Elderly: A Review of Current Evidence
Jintao Chen, Xinyi Wang, Zhe‐rong Xu
Journal of Pain Research (2023) Vol. Volume 16, pp. 2309-2319
Open Access | Times Cited: 23
Advancing Research and Treatment: An Overview of Clinical Trials in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Future Perspectives
Katharine A. Seton, José Espejo, Karen Giménez-Orenga, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 325-325
Open Access | Times Cited: 9
Pain as a predictor of heavy drinking and any drinking lapses in the COMBINE study and the UK Alcohol Treatment Trial
Katie Witkiewitz, Kevin E. Vowles, Elizabeth McCallion, et al.
Addiction (2015) Vol. 110, Iss. 8, pp. 1262-1271
Open Access | Times Cited: 89
Recent progress in the development of Toll-like receptor (TLR) antagonists
Mahesh Chandra Patra, Sangdun Choi
Expert Opinion on Therapeutic Patents (2016) Vol. 26, Iss. 6, pp. 719-730
Closed Access | Times Cited: 80
Orthopaedic management of the Ehlers–Danlos syndromes
William B. Ericson, Roger Wolman
American Journal of Medical Genetics Part C Seminars in Medical Genetics (2017) Vol. 175, Iss. 1, pp. 188-194
Open Access | Times Cited: 78
Low-dose naltrexone (LDN): A promising treatment in immune-related diseases and cancer therapy
Zijian Li, Yue You, Noreen Griffin, et al.
International Immunopharmacology (2018) Vol. 61, pp. 178-184
Closed Access | Times Cited: 70
Low-Dose Naltrexone for Chronic Pain: Update and Systemic Review
Phillip S. Kim, Michael Fishman
Current Pain and Headache Reports (2020) Vol. 24, Iss. 10
Closed Access | Times Cited: 56
A medical mystery of complex regional pain syndrome
Jabril Eldufani, Nyruz Elahmer, Gilbert Blaise
Heliyon (2020) Vol. 6, Iss. 2, pp. e03329-e03329
Open Access | Times Cited: 51
TLR4 biased small molecule modulators
Cong Lin, Hongshuang Wang, Miyuan Zhang, et al.
Pharmacology & Therapeutics (2021) Vol. 228, pp. 107918-107918
Closed Access | Times Cited: 44
Pharmacological Management of Orofacial Pain
Marcela Romero‐Reyes, Sherwin Arman, Antonia Teruel, et al.
Drugs (2023) Vol. 83, Iss. 14, pp. 1269-1292
Closed Access | Times Cited: 17
The Safety and Efficacy of Low-Dose Naltrexone in Patients with Fibromyalgia: A Systematic Review
Juan Yang, Kyung-Min Shin, Alex Do, et al.
Journal of Pain Research (2023) Vol. Volume 16, pp. 1017-1023
Open Access | Times Cited: 16
Effective Doses of Low-Dose Naltrexone for Chronic Pain – An Observational Study
Norman J. Marcus, Lexi Robbins, Aya Araki, et al.
Journal of Pain Research (2024) Vol. Volume 17, pp. 1273-1284
Open Access | Times Cited: 6
Treatment of Hailey-Hailey Disease With Low-Dose Naltrexone
Lauren N. Albers, Jack L. Arbiser, Ron J. Feldman
JAMA Dermatology (2017) Vol. 153, Iss. 10, pp. 1018-1018
Open Access | Times Cited: 56
Pharmacological Management of Chronic Pelvic Pain in Women
Erin T. Carey, Sara R. Till, Sawsan As‐Sanie
Drugs (2017) Vol. 77, Iss. 3, pp. 285-301
Closed Access | Times Cited: 53
Microglial Modulation as a Target for Chronic Pain: From the Bench to the Bedside and Back
Elena S. Haight, Thomas E. Forman, Stephanie A. Cordonnier, et al.
Anesthesia & Analgesia (2019) Vol. 128, Iss. 4, pp. 737-746
Open Access | Times Cited: 53
Extended-release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living with HIV and Alcohol use Disorders Transitioning to the Community: Results From a Double-Blind, Placebo-Controlled Trial
Sandra A. Springer, Angela Di Paola, Russell Barbour, et al.
JAIDS Journal of Acquired Immune Deficiency Syndromes (2018) Vol. 79, Iss. 1, pp. 92-100
Open Access | Times Cited: 52
The uses of naltrexone in dermatologic conditions
Brigette Lee, Dirk M. Elston
Journal of the American Academy of Dermatology (2018) Vol. 80, Iss. 6, pp. 1746-1752
Closed Access | Times Cited: 52
Page 1 - Next Page

Scroll to top